Skip to Content

Cancers, Volume 16, Issue 22

2024 November-2 - 169 articles

Cover Story: Brain metastases are common in lung cancer, posing distinct clinical challenges. Advances in radiation and systemic therapies underscore the need for an improved integration of multidisciplinary approaches to optimize both survival and symptomatic burden. Radiotherapy prioritizing durable control with minimal neurocognitive toxicity, as well as systemic agents with central nervous system activity, can be leveraged to deliver increasingly personalized regimens. Clinical trials are ongoing to elucidate how to integrate clinical features, tumor biology, and predictive biomarkers to effectively downstage intracranial disease and consolidate persistent metastases. Further work is needed to design risk-adapted strategies to balance intracranial efficacy with patient values while preserving neurocognitive. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (169)

  • Article
  • Open Access
2 Citations
1,945 Views
20 Pages

Prealbumin Prognostic Score: A Novel Prognostic Indicator After Radical Gastrectomy in Patients with Gastric Cancer

  • Ryota Matsui,
  • Souya Nunobe,
  • Motonari Ri,
  • Rie Makuuchi,
  • Tomoyuki Irino,
  • Masaru Hayami,
  • Manabu Ohashi and
  • Takeshi Sano

20 November 2024

Background: This study aimed to determine whether the prealbumin prognostic score (PPS), a novel indicator using prealbumin instead of albumin in the modified Glasgow Prognostic Score (mGPS), is a better predictive marker postoperatively in patients...

  • Article
  • Open Access
5 Citations
3,649 Views
17 Pages

GPX4 and FSP1 Expression in Lung Adenocarcinoma: Prognostic Implications and Ferroptosis-Based Therapeutic Strategies

  • Hirotomo Takahara,
  • Takumi Kanazawa,
  • Haruna Oshita,
  • Yoshinobu Tomita,
  • Yuri Hananoi,
  • Sachiko Ishibashi,
  • Masumi Ikeda,
  • Asuka Furukawa,
  • Mayumi Kinoshita and
  • Kouhei Yamamoto
  • + 7 authors

20 November 2024

Background: Primary lung cancer is among the cancers with the poorest prognosis, having the highest mortality rate among men and the second highest among women in Japan. While surgery is the primary treatment, advanced stages often require pharmacoth...

  • Systematic Review
  • Open Access
9 Citations
6,746 Views
24 Pages

Head and Neck Squamous Cell Carcinoma with Distant Metastasis: A Systematic Review and Meta-Analysis

  • Antonio Daloiso,
  • Leonardo Franz,
  • Tiziana Mondello,
  • Matteo Tisato,
  • Michael Negrisolo,
  • Paolo Zanatta,
  • Cosimo de Filippis,
  • Laura Astolfi and
  • Gino Marioni

20 November 2024

Background/Objectives: Distant metastasis (DM), though uncommon at initial presentation, significantly worsens the prognosis of head and neck squamous cell carcinomas (HNSCCs). This review aimed to investigate the occurrence rates, patterns, and impl...

  • Systematic Review
  • Open Access
4 Citations
1,995 Views
19 Pages

Anthracycline-Induced Subclinical Right Ventricular Dysfunction in Breast Cancer Patients: A Systematic Review and Meta-Analysis

  • Andrea Faggiano,
  • Elisa Gherbesi,
  • Chiara Giordano,
  • Giacomo Gamberini,
  • Marco Vicenzi,
  • Cesare Cuspidi,
  • Stefano Carugo,
  • Carlo M. Cipolla and
  • Daniela M. Cardinale

20 November 2024

Aim: This meta-analysis aims to evaluate the impact of anthracycline chemotherapy on subclinical right ventricular (RV) dysfunction in breast cancer patients, using traditional echocardiographic parameters and strain-based measures, such as the RV gl...

  • Review
  • Open Access
5 Citations
5,464 Views
12 Pages

20 November 2024

KRAS mutation is one of the most common oncogenic drivers in non-small cell lung cancer. Since its discovery about four decades ago, drug development targeting KRAS has been met with countless failures. Recently, KRAS G12C, a subvariant of KRAS, beca...

  • Article
  • Open Access
4 Citations
1,971 Views
11 Pages

Cladribine-Based Therapy for Acute Myeloid Leukemia in Child, Adolescent, and Early Young Adult Patients: The MD Anderson Cancer Center Experience

  • David McCall,
  • Shaikha Alqahtani,
  • Moriah Budak,
  • Irtiza Sheikh,
  • Aaron E. Fan,
  • Ramya Ramakrishnan,
  • Cesar Nunez,
  • Michael Roth,
  • Miriam B. Garcia and
  • Tapan Kadia
  • + 10 authors

20 November 2024

Background: Cladribine-based combination chemotherapy has demonstrated promising efficacy in patients with relapsed/refractory adult acute myeloid leukemia (AML), prompting its increased utilization in the frontline; in pediatrics, it has been typica...

  • Perspective
  • Open Access
27 Citations
6,599 Views
21 Pages

Artificial Intelligence–Driven Computational Approaches in the Development of Anticancer Drugs

  • Pankaj Garg,
  • Gargi Singhal,
  • Prakash Kulkarni,
  • David Horne,
  • Ravi Salgia and
  • Sharad S. Singhal

20 November 2024

The integration of AI has revolutionized cancer drug development, transforming the landscape of drug discovery through sophisticated computational techniques. AI-powered models and algorithms have enhanced computer-aided drug design (CADD), offering...

  • Communication
  • Open Access
1 Citations
1,432 Views
8 Pages

Adverse Events as a Function of Biological Sex in a Multicenter Clinical Trial of Melanoma Vaccines

  • Catherine E. Lyons,
  • Ruyun Jin,
  • Aaron D. Smith,
  • Hong Zhu and
  • Craig L. Slingluff

20 November 2024

Background/Objective: Biological females experience more autoimmune disease than males and more treatment-related adverse events (TRAEs) after immune checkpoint blockade therapy. However, little is known about sex-related differences in TRAEs after c...

  • Review
  • Open Access
8 Citations
2,853 Views
11 Pages

Kill Two Birds with One Stone? The Effect of Helicobacter pylori Eradication in Decreased Prevalence of Gastric Cancer and Colorectal Cancer

  • Yang-Che Kuo,
  • Hung-Ju Ko,
  • Lo-Yip Yu,
  • Shou-Chuan Shih,
  • Horng-Yuan Wang,
  • Ying-Chun Lin and
  • Kuang-Chun Hu

20 November 2024

The connection between microbial infections and tumor formation is notably exemplified by Helicobacter pylori (H. pylori) and its association with gastric cancer (GC) and colorectal cancer (CRC). While early studies hinted at a link between H. pylori...

  • Article
  • Open Access
14 Citations
4,580 Views
28 Pages

Lung and Colon Cancer Detection Using a Deep AI Model

  • Nazmul Shahadat,
  • Ritika Lama and
  • Anna Nguyen

20 November 2024

Lung and colon cancers are among the leading causes of cancer-related mortality worldwide. Early and accurate detection of these cancers is crucial for effective treatment and improved patient outcomes. False or incorrect detection is harmful. Accura...

  • Article
  • Open Access
6 Citations
2,364 Views
12 Pages

Sequential Use of Sorafenib and Regorafenib in Hepatocellular Cancer Recurrence After Liver Transplantation: Treatment Strategies and Outcomes

  • Mehmet Fatih Ozbay,
  • Hakan Harputluoglu,
  • Mustafa Karaca,
  • Omer Tekin,
  • Mehmet Ali Nahit Şendur,
  • Muhammed Ali Kaplan,
  • Berksoy Sahin,
  • Caglayan Geredeli,
  • Fatih Teker and
  • Ali Murat Tatlı
  • + 10 authors

20 November 2024

Background and Aims: During liver transplantation, hepatocellular carcinoma (HCC) recurrence remains a critical challenge for patient survival. Targeted therapies, such as sorafenib and regorafenib, have been utilized to manage relapsed HCC in this u...

  • Article
  • Open Access
2,060 Views
13 Pages

Patient Outcomes in Resected Combined Hepatocellular Cholangiocarcinoma (cHCC-ICC) and Intrahepatic Cholangiocarcinoma: A Single Center Study

  • Rick Y. Lin,
  • Doga Kahramangil,
  • Muhammet Ozer,
  • Thomas J. George,
  • Ibrahim Nassour,
  • Steven J. Hughes,
  • Ali Zarrinpar and
  • Ilyas Sahin

20 November 2024

Background/Objectives: Combined hepatocellular cholangiocarcinoma (cHCC-ICC) is a rare malignancy that involves a combination of features of hepatocellular carcinoma and intrahepatic cholangiocarcinoma (ICC) and exhibits a more aggressive clinical co...

  • Article
  • Open Access
4 Citations
2,597 Views
17 Pages

Association of HLA-G Expression, Its Genetic Variants and Related Neuro-Immunomodulation with Characteristics of Bladder Carcinoma

  • Vladimira Durmanova,
  • Iveta Mikolaskova,
  • Eszter Zsemlye,
  • Agata Ocenasova,
  • Helena Bandzuchova,
  • Magda Suchankova,
  • Boris Kollarik,
  • Patrik Palacka,
  • Milan Zvarik and
  • Luba Hunakova
  • + 1 author

20 November 2024

Background: Human leukocyte antigen G (HLA-G) is an immune checkpoint molecule with immunosuppressive and anti-inflammatory activities. It belongs to class I non-classical major histocompatibility complex molecules and has been upregulated in various...

  • Article
  • Open Access
4 Citations
3,801 Views
17 Pages

Molecular and In Silico Analysis of the CHEK2 Gene in Individuals with High Risk of Cancer Predisposition from Türkiye

  • Ozkan Ozdemir,
  • Brittany L. Bychkovsky,
  • Busra Unal,
  • Gizem Onder,
  • Ufuk Amanvermez,
  • Eylul Aydin,
  • Berk Ergun,
  • Ilayda Sahin,
  • Merve Gokbayrak and
  • Nihat Bugra Agaoglu
  • + 8 authors

20 November 2024

Background and Objectives: Checkpoint kinase 2 (CHEK2) is a tumor suppressor gene involved in DNA repair and cell cycle regulation. Pathogenic or likely pathogenic (P/LP) variants in CHEK2 are associated with increased cancer risk. Conversely, r...

  • Article
  • Open Access
1 Citations
1,945 Views
18 Pages

Low-Dose Eribulin Promotes NK Cell-Mediated Therapeutic Efficacy in Bladder Cancer

  • Zaineb Hassouneh,
  • Onika D. V. Noel,
  • Niannian Ji,
  • Michelle E. Kim,
  • Jordan Svatek,
  • Robert S. Svatek,
  • April L. Risinger and
  • Neelam Mukherjee

19 November 2024

Despite its immunogenic nature, bladder cancer (BCa) responds sub-optimally to FDA-approved immunotherapy. Background/Objectives: We have previously shown that natural killer (NK) cells are major contributors to overall patient survival in BCa. In ou...

  • Review
  • Open Access
3 Citations
2,268 Views
9 Pages

Adjuvant Radiation Therapy in Desmoplastic Melanoma: A Scoping Review

  • Christina Setareh Sharafi,
  • B. Ashleigh Guadagnolo,
  • Kelly C. Nelson and
  • Devarati Mitra

19 November 2024

Desmoplastic melanoma (DM) is an uncommon subtype of cutaneous melanoma that presents distinct diagnostic and treatment challenges. This review aims to explore the role of adjuvant radiation therapy (RT) in managing DM. To evaluate this question, we...

  • Review
  • Open Access
1 Citations
2,696 Views
17 Pages

19 November 2024

Identifying proteins that act in tumor invasiveness and metastasis remains a critical unmet need in our search for effective cancer therapy. Hsp90, an abundant intracellular chaperone protein, plays a key role in maintaining cell homeostasis, and its...

  • Article
  • Open Access
1 Citations
3,499 Views
14 Pages

Dose-Reduced FLA-IDA in Combination with Venetoclax Is an Effective and Safe Salvage Therapy in Relapsed and Refractory Acute Myeloid Leukemia (R/R AML)

  • Martin Schönrock,
  • Piet Sonnemann,
  • Nina Michalowski,
  • Michael Heuser,
  • Felicitas Thol,
  • Francis Ayuketang Ayuk,
  • Christine Wolschke,
  • Evgeny Klyuchnikov,
  • Carsten Bokemeyer and
  • Sophia Cichutek
  • + 1 author

19 November 2024

Background: Despite the development of targeted therapies in first-line AML, complete remissions (CR) cannot be achieved in 30–40%, and relapse rates remain high. In R/R AML the intensive treatment regimen of fludarabine, cytarabine, idarubicin...

  • Article
  • Open Access
3 Citations
2,181 Views
13 Pages

19 November 2024

Introduction: In recent years, several inflammation-related factors and nutritional parameters have been evaluated to develop prognostic scores as potential biomarkers in non-small-cell lung cancer (NSCLC) patients receiving immune checkpoint inhibit...

  • Review
  • Open Access
4 Citations
1,667 Views
20 Pages

A Pathological Assessment of the Microvasculature of Biliary Tract Neoplasms Referring to Pre-Existing Blood Vessels and Vessel Co-Option

  • Yasuni Nakanuma,
  • Zihan Li,
  • Yasunori Sato,
  • Motoko Sasaki,
  • Kenichi Harada,
  • Yuko Kakuda and
  • Takashi Sugino

19 November 2024

There are several types of microvasculature supplying neoplasms: “newly formed blood vessels” (neoangiogenesis), which are a component of the tumor microenvironment (TME) of invasive carcinoma with wound healing-like reaction; and “...

  • Article
  • Open Access
2 Citations
2,446 Views
17 Pages

19 November 2024

Background: As the first sentinel lymph nodes (SLN) in lung cancer are most likely to harbor metastasis, their non-invasive identification could have a significant role in future treatments. We investigated the feasibility of adding an SLN procedure...

  • Review
  • Open Access
7 Citations
3,767 Views
17 Pages

19 November 2024

Metastatic colorectal cancer is a leading cause of cancer-related death across the world. The treatment paradigm has shifted away from systemic chemotherapy alone to include targeted therapy and immunotherapy. The past two decades have been character...

  • Review
  • Open Access
3 Citations
4,050 Views
24 Pages

Cellular Therapies for Multiple Myeloma: Engineering Hope

  • Sarah Vera-Cruz,
  • Maria Jornet Culubret,
  • Verena Konetzki,
  • Miriam Alb,
  • Sabrina R. Friedel,
  • Michael Hudecek,
  • Hermann Einsele,
  • Sophia Danhof and
  • Lukas Scheller

19 November 2024

Multiple myeloma (MM) treatment remains challenging due to its relapsed/refractory disease course as well as intra- and inter-patient heterogeneity. Cellular immunotherapies, especially chimeric antigen receptor (CAR)-T cells targeting B cell maturat...

  • Article
  • Open Access
1,911 Views
11 Pages

Cervical CT Angiography: The Advantage of Ultra-High-Resolution CT Versus Conventional HRCT

  • Junji Ito,
  • Tsuneo Yamashiro,
  • Hayato Tomita,
  • Joichi Heianna,
  • Sadayuki Murayama and
  • Akihiro Nishie

19 November 2024

Background/Objectives: Pre-treatment depiction of the cervical arteries is important for better intra-arterial infusion therapy of malignant head and neck tumors. There have not been any studies on the image quality of ultra-high-resolution computed...

  • Systematic Review
  • Open Access
7 Citations
4,119 Views
14 Pages

Prostate-Specific Membrane Antigen (PSMA) PET/CT in the Detection and Diagnosis of Hepatocellular Carcinoma (HCC): A Systematic Review and Meta-Analysis

  • Nicholas Hannah,
  • Catherine Yu,
  • Leya Nedumannil,
  • James Haridy,
  • Grace Kong,
  • Alex Boussioutas and
  • Siddharth Sood

19 November 2024

Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) is widely used in prostate cancer. Recent studies indicate hepatocellular carcinoma (HCC) demonstrates PSMA PET uptake. The diagnostic accuracy of PSMA PET for HCC is not kn...

  • Systematic Review
  • Open Access
3 Citations
1,651 Views
13 Pages

Response to Bridging Therapy as a Prognostic Indicator of Post-Transplantation Hepatocellular Carcinoma Recurrence and Survival: A Systematic Review

  • Paweł Topolewski,
  • Dariusz Łaski,
  • Martyna Łukasiewicz,
  • Piotr Domagała,
  • Roeland F. de Wilde and
  • Wojciech G. Polak

18 November 2024

Liver transplantation (LT) is one of the most effective treatments for hepatocellular carcinoma (HCC) in cirrhotic livers. Neoadjuvant bridging treatment in patients qualifying and listed for LT is advised but is still debatable owing to the low leve...

  • Article
  • Open Access
2 Citations
2,240 Views
19 Pages

Altered Mechanobiology of PDAC Cells with Acquired Chemoresistance to Gemcitabine and Paclitaxel

  • Alessandro Gregori,
  • Cecilia Bergonzini,
  • Mjriam Capula,
  • Rick Rodrigues de Mercado,
  • Erik H. J. Danen,
  • Elisa Giovannetti and
  • Thomas Schmidt

18 November 2024

Background: Pancreatic ductal adenocarcinoma acquired resistance to chemotherapy poses a major limitation to patient survival. Despite understanding some biological mechanisms of chemoresistance, much about those mechanisms remains to be uncovered. M...

  • Article
  • Open Access
1 Citations
1,771 Views
15 Pages

18 November 2024

Background: Cancer cells exhibit altered metabolism whereby glucose is preferentially utilized to produce lactate through aerobic glycolysis. The increase in lactate production creates an acidic microenvironment that supports tumor progression and me...

  • Article
  • Open Access
3 Citations
5,513 Views
23 Pages

Brief Magnetic Field Exposure Stimulates Doxorubicin Uptake into Breast Cancer Cells in Association with TRPC1 Expression: A Precision Oncology Methodology to Enhance Chemotherapeutic Outcome

  • Viresh Krishnan Sukumar,
  • Yee Kit Tai,
  • Ching Wan Chan,
  • Jan Nikolas Iversen,
  • Kwan Yu Wu,
  • Charlene Hui Hua Fong,
  • Joline Si Jing Lim and
  • Alfredo Franco-Obregón

18 November 2024

Background/Objectives: Doxorubicin (DOX) is commonly used as a chemotherapeutic agent for the treatment of breast cancer. Nonetheless, its systemic delivery via intravenous injection and toxicity towards healthy tissues commonly result in a broad ran...

  • Article
  • Open Access
4 Citations
2,154 Views
22 Pages

Immunophenotypic Profile of Adult Glioblastoma IDH-Wildtype Microenvironment: A Cohort Study

  • Sofia Asioli,
  • Lidia Gatto,
  • Uri Vardy,
  • Claudio Agostinelli,
  • Vincenzo Di Nunno,
  • Simona Righi,
  • Alicia Tosoni,
  • Francesca Ambrosi,
  • Stefania Bartolini and
  • Enrico Franceschi
  • + 1 author

18 November 2024

Background: Glioblastoma IDH-wildtype (GBM IDH-wt) is the most aggressive brain tumor in adults and is characterized by an immunosuppressive microenvironment. Different factors shaping its tumor microenvironment (TME) regulate tumor progression and t...

  • Review
  • Open Access
15 Citations
8,566 Views
14 Pages

Liposarcoma: A Journey into a Rare Tumor’s Epidemiology, Diagnosis, Pathophysiology, and Limitations of Current Therapies

  • Emily Jonczak,
  • Julie Grossman,
  • Francesco Alessandrino,
  • Crystal Seldon Taswell,
  • Jaylou M. Velez-Torres and
  • Jonathan Trent

18 November 2024

Sarcomas are a heterogeneous group of neoplasms that develop from bone and soft tissue. Approximately 80% of sarcomas affect soft tissue, with liposarcoma being one of the most common types, accounting for approximately 13–20% of all soft-tissu...

  • Article
  • Open Access
2 Citations
2,670 Views
12 Pages

First-Line Combination of R-CHOP with the PDE4 Inhibitor Roflumilast for High-Risk DLBCL

  • Adolfo E. Diaz Duque,
  • Pedro S. S. M. Ferrari,
  • Purushoth Ethiraj,
  • Carine Jaafar,
  • Zhijun Qiu,
  • Kenneth Holder,
  • Mathew J. Butler,
  • Gabriela Huelgas-Morales,
  • Anand Karnad and
  • Ricardo C. T. Aguiar
  • + 1 author

18 November 2024

Background: Diffuse large B-cell lymphoma (DLBCL) is a common and often fatal malignancy. The standard-of-care immunochemotherapy, R-CHOP, cures only about 60% of DLBCL patients. Improving this cure rate will likely require the effective translation...

  • Article
  • Open Access
1 Citations
1,996 Views
11 Pages

17 November 2024

Background/Objectives: The recurrence of glioblastoma is an inevitable event in this disease’s course. In this study, we sought to identify the metabolomic signature in patients with recurrent glioblastomas undergoing surgery and radiation ther...

  • Review
  • Open Access
19 Citations
16,490 Views
25 Pages

17 November 2024

With recent technological advances and significant progress in understanding the pathogenesis of acute myeloid leukemia (AML), the updated fifth edition WHO Classification (WHO-HAEM5) and the newly introduced International Consensus Classification (I...

  • Article
  • Open Access
1 Citations
1,756 Views
22 Pages

Can the Analysis of Toll-like Receptors (TLR) on NK and NKT-like Cells Improve Gastric Cancer Diagnostics and Treatment?

  • Marek Kos,
  • Krzysztof Bojarski,
  • Paulina Mertowska,
  • Sebastian Mertowski,
  • Piotr Tomaka,
  • Monika Zaborek-Łyczba,
  • Jakub Łyczba,
  • Łukasz Dziki and
  • Ewelina Grywalska

17 November 2024

Background/Objectives: The aim of this study was to determine the assessment of the percentage of NK and NKT-like cells expressing Toll-like receptors (TLR-2, TLR-3, TLR-4, and TLR-9) in patients with gastric cancer (GC) compared with healthy volunte...

  • Article
  • Open Access
2 Citations
3,371 Views
13 Pages

Factors Affecting Cancer Mortality in Young Adults: Findings from a Prospective Cohort Study

  • Ngoan T. Le,
  • Yen T.-H. Pham,
  • Linh T. Le,
  • Hang V. Dao,
  • Chihaya Koriyama,
  • Toan H. Ha,
  • Maureen Lichtveld,
  • Suresh V. Kuchipudi,
  • Nhi Y.-N. Huynh and
  • Hung N. Luu
  • + 1 author

17 November 2024

Background/Objectives: Cancer incidence in young adults or those aged 15–49 years old has increased during the past decade. Knowledge about the risk factors for cancer-related deaths in young adults is limited, particularly in low- and middle-i...

  • Article
  • Open Access
1,360 Views
10 Pages

An Exploratory Study: Can Native T1 Mapping Differentiate Sarcoma from Benign Soft Tissue Tumors at 1.5 T and 3 T?

  • Laura Dupont,
  • Bénédicte M. A. Delattre,
  • Marta Sans Merce,
  • Pierre Alexandre Poletti and
  • Sana Boudabbous

17 November 2024

Background/Objectives: T1 relaxation time has been shown to be valuable in detecting and characterizing tumors in various organs. This study aims to determine whether native T1 relaxation time can serve as a useful tool in distinguishing sarcomas fro...

  • Article
  • Open Access
4 Citations
3,961 Views
21 Pages

A New Approach of Detecting ALK Fusion Oncogenes by RNA Sequencing Exon Coverage Analysis

  • Galina Zakharova,
  • Maria Suntsova,
  • Elizaveta Rabushko,
  • Tharaa Mohammad,
  • Alexey Drobyshev,
  • Alexander Seryakov,
  • Elena Poddubskaya,
  • Alexey Moisseev,
  • Anastasia Smirnova and
  • Anton Buzdin
  • + 5 authors

16 November 2024

Background: In clinical practice, various methods are used to identify ALK gene rearrangements in tumor samples, ranging from “classic” techniques, such as IHC, FISH, and RT-qPCR, to more advanced highly multiplexed approaches, such as Na...

  • Review
  • Open Access
5 Citations
4,079 Views
24 Pages

Psychological Interventions for Insomnia in Patients with Cancer: A Scoping Review

  • Alyssa Alinda Gonzalez,
  • Gladys Janice Jimenez-Torres,
  • Aline Rozman de Moraes,
  • Yimin Geng,
  • Varsha Pawate,
  • Rida Khan,
  • Santhosshi Narayanan and
  • Sriram Yennurajalingam

16 November 2024

Background/Objectives: Insomnia is a frequent and distressing symptom with limited treatment in patients with cancer. Among the available treatments for insomnia, psychological interventions are some of the most assessed. While studies and reviews sh...

  • Article
  • Open Access
4 Citations
2,889 Views
18 Pages

Characterization of Breast Cancer Intra-Tumor Heterogeneity Using Artificial Intelligence

  • Ayat G. Lashen,
  • Noorul Wahab,
  • Michael Toss,
  • Islam Miligy,
  • Suzan Ghanaam,
  • Shorouk Makhlouf,
  • Nehal Atallah,
  • Asmaa Ibrahim,
  • Mostafa Jahanifar and
  • Emad A. Rakha
  • + 10 authors

16 November 2024

Intra-tumor heterogeneity (ITH) is a fundamental characteristic of breast cancer (BC), influencing tumor progression, prognosis, and therapeutic responses. However, the complexity of ITH in BC makes its accurate characterization challenging. This stu...

  • Article
  • Open Access
1 Citations
1,788 Views
17 Pages

SLFN12 Expression Significantly Effects the Response to Chemotherapy Drugs in Triple-Negative Breast Cancer

  • Savannah R. Brown,
  • Emilie Erin Vomhof-DeKrey,
  • Sarmad Al-Marsoummi,
  • Trysten Beyer,
  • Bo Lauckner,
  • Mckenzie Samson,
  • Sarah Sattar,
  • Nicholas D. Brown and
  • Marc D. Basson

16 November 2024

Background/Objectives: Schlafen12 (SLFN12) is an intermediate human Schlafen protein shown to correlate with survivability in triple-negative breast cancer (TNBC). SLFN12 causes differential expressions of significant cancer genes, but how they chang...

  • Article
  • Open Access
6 Citations
2,176 Views
22 Pages

The Descriptive and Disproportionality Assessment of EudraVigilance Database Reports on Capecitabine Induced Cardiotoxicity

  • Razvan Constantin Vonica,
  • Anca Butuca,
  • Andreea Loredana Vonica-Tincu,
  • Claudiu Morgovan,
  • Manuela Pumnea,
  • Remus Calin Cipaian,
  • Razvan Ovidiu Curca,
  • Florina Batar,
  • Vlad Vornicu and
  • Felicia Gabriela Gligor
  • + 4 authors

16 November 2024

Capecitabine (CAP) is one of the most commonly prescribed fluoropyrimidines in oncology, especially in the treatment of colon cancer. Cardiac toxicity is a severe and potentially lethal adverse drug reaction (ADR) against fluoropyrimidines. Cardiac A...

  • Article
  • Open Access
2,394 Views
15 Pages

Black Soybean Seed Coat Extract Suppresses Gut Tumorigenesis by Augmenting the Production of Gut Microbiota-Derived Short-Chain Fatty Acids

  • Yasuyuki Shimizu,
  • Shunta Hirano,
  • Mohammed Salah,
  • Namiko Hoshi,
  • Yoko Yamashita,
  • Takeshi Fukumoto,
  • Naritoshi Mukumoto,
  • Ai Nakaoka,
  • Takeaki Ishihara and
  • Ryohei Sasaki
  • + 2 authors

15 November 2024

Background: Proanthocyanidins (PACs) from black soybean seed coat have antioxidant and anti-tumorigenic properties. We investigated the anti-tumor properties and mechanisms of action of PACs on colorectal cancer (CRC). Methods: We fed the APCmin/+ mi...

  • Article
  • Open Access
2 Citations
3,629 Views
13 Pages

Risk of Postoperative Hemorrhage After Glioma Surgery in Patients with Preoperative Acetylsalicylic Acid

  • Anatoli Pinchuk,
  • Nikolay Tonchev,
  • Claudia A. Dumitru,
  • Belal Neyazi,
  • Klaus-Peter Stein,
  • I. Erol Sandalcioglu and
  • Ali Rashidi

15 November 2024

Background/Objectives: Patients with gliomas show an increased risk of spontaneous hemorrhages throughout the disease. Simultaneously, the number of patients taking acetylsalicylic acid (ASA) for primary and secondary prophylaxis is rising in daily c...

  • Article
  • Open Access
1,744 Views
13 Pages

Impact of MASLD on Portal Vein Thrombosis Following Hepatectomy for Liver Cancer

  • Yoshito Wada,
  • Koji Okuda,
  • Shin Sasaki,
  • Shigeo Shimose,
  • Takamichi Nishida,
  • Hisaaki Shimokobe,
  • Yuichi Nagao,
  • Takayuki Torigoe,
  • Koji Hayashi and
  • Tetsuo Imamura
  • + 2 authors

15 November 2024

Background: Due to the increasing global prevalence of non-alcoholic fatty liver disease (NAFLD), which is closely linked to metabolic disorders, there has been a rise in the number of patients with NAFLD undergoing hepatectomy. The metabolic disorde...

  • Article
  • Open Access
3 Citations
1,954 Views
11 Pages

PSMA-Guided Imaging and Therapy of Advanced Adenoid Cystic Carcinomas and Other Salivary Gland Carcinomas

  • Nils F. Trautwein,
  • Andreas Brendlin,
  • Gerald Reischl,
  • Moritz Mattke,
  • Frank Paulsen,
  • Hubert Loewenheim,
  • Lars Zender,
  • Christian la Fougère and
  • Helmut Dittmann

15 November 2024

SGCs are rare malignancies, accounting for less than 1% of all head and neck cancers [...]

  • Article
  • Open Access
1,909 Views
26 Pages

Kallikrein-Related Peptidase 6 Contributes to Murine Intestinal Tumorigenesis Driven by a Mutant Adenomatous polyposis coli Gene

  • Teodora G. Georgieva,
  • Dalila Darmoul,
  • Hwudaurw Chen,
  • Haiyan Cui,
  • Photini F. S. Rice,
  • Jennifer K. Barton,
  • David G. Besselsen and
  • Natalia A. Ignatenko

15 November 2024

Background/Objectives: The objective of this study was to assess the role of a secreted serine protease, kallikrein-related peptidase 6 (KLK6), during colorectal tumorigenesis driven by a mutant Adenomatous polyposis coli (APC) tumor suppressor gene....

  • Review
  • Open Access
3 Citations
5,005 Views
27 Pages

Posterior Retroperitoneal Laparoscopic Adrenalectomy: An Anatomical Essay and Surgical Update

  • Bogdan Ovidiu Feciche,
  • Vlad Barbos,
  • Alexandru Big,
  • Daniel Porav-Hodade,
  • Alin Adrian Cumpanas,
  • Silviu Constantin Latcu,
  • Flavia Zara,
  • Alina Cristina Barb,
  • Cristina-Stefania Dumitru and
  • Dorin Novacescu
  • + 2 authors

15 November 2024

Posterior retroperitoneal laparoscopic adrenalectomy (PRLA) has emerged as a revolutionary, minimally invasive technique for adrenal gland surgery, offering significant advantages over traditional open approaches. This narrative review aims to provid...

  • Communication
  • Open Access
3 Citations
2,358 Views
10 Pages

Carcinoma-Associated Fibroblasts Accelerate Growth and Invasiveness of Breast Cancer Cells in 3D Long-Term Breast Cancer Models

  • Kingsley O. Osuala,
  • Joshua Heyza,
  • Zhiguo Zhao,
  • Yong Xu,
  • Kamiar Moin,
  • Kyungmin Ji and
  • Raymond R. Mattingly

15 November 2024

Background/Objectives: Carcinoma-associated fibroblasts (CAFs), a prominent cell type in the tumor microenvironment (TME), significantly contributes to cancer progression through interactions with cancer cells and other TME components. Consequently,...

of 4

XFacebookLinkedIn
Cancers - ISSN 2072-6694